Financial Management Network’s iShares Biotechnology ETF IBB Stock Holding History

Financial Management Network’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,359	Closed	-$212K	–	132
2021 Q3	$212K	Hold	1,359	–	–	0.11%	121
2021 Q2	$224K	Hold	1,359	–	–	0.11%	115
2021 Q1	$210K	Buy	1,359 +100	+8%	+$15.9K	0.11%	119
2020 Q4	$208K	Buy	+1,259	New	+$180K	0.13%	106

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Financial Management Network's IBB Position: Q4 2021 in Review

Financial Management Network sold out of iShares Biotechnology ETF (IBB) in Q4 2021, closing a stake of 1,359 shares — an estimated $212K sold.

Financial Management Network first reported a position in IBB in Q4 2020 and held it in 4 quarters. The position peaked at $224K in Q2 2021. 962 funds tracked by Wall St. Rank hold IBB as of Q4 2021.

Financial Management Network reported no remaining iShares Biotechnology ETF position as of Q4 2021 after selling out during the quarter.
Financial Management Network sold 1,359 iShares Biotechnology ETF shares in Q4 2021, an estimated $212K.
Financial Management Network first reported a position in iShares Biotechnology ETF in Q4 2020 and held it in 4 quarters.
Financial Management Network's iShares Biotechnology ETF position peaked at $224K in Q2 2021.
962 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2021.

Based on Financial Management Network's 13F filing for Q4 2021, filed 19 Jan 2022.